In 87 out of 273 MG patients, serum levels of interleukin (IL)-4, IL-10, IL-6, IL-17A, IL-23, and IFN-γ before and 4 weeks after the first session of LPE therapy were detected by ELISA. Here, IL17A is linked to myasthenia gravis.